Skip to main content
OpenTrials
Completed

NCT Number: NCT01852903

Comparative Bioavailability of Two Forms of Vitamin C

The purpose of this study is to compare levels of vitamin C in the blood over the 24 hour period following a single 1000 mg dose of vitamin C from ascorbic acid, calcium ascorbate and placebo.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

KGK Synergize Inc

London, Ontario, N6A 5R8, Canada

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy as determined by laboratory results and medical history
  • Females not of child bearing potential
  • BMI 18-30 kg/m2
  • Agrees to consume a low vitamin C diet
  • Non-smoker or ex-smoker >1 year

Exclusion criteria

  • Pregnant, breastfeeding, or planning to become pregnant during the trial
  • Alcohol >2 drinks per day; alcohol or drug abuse within the past year
  • Cardiac conditions
  • Duodenal ulcer or gastric ulcer, gastritis, hiatus hernia, or gastroesophageal reflux disease (GERD) within past 3 months
  • History irritable bowel syndrome, malabsorption or significant GI disease
  • History of kidney stones
  • Use of medications known to interact with vitamin C
  • Use of supplements containing vitamin C
  • Use of anticoagulants (warfarin), barbiturates, tetracycline antibiotics, beta-blockers, cyclosporine, prednisone, tricyclic antidepressants, diuretics and nitrate medications
  • History of or current diagnosis of cancer
  • Uncontrolled hypertension
  • History of diabetes, renal disease and/or liver disease
  • Unstable psychiatric disorder
  • History of or current immunocompromise
  • History of hemochromatosis or hemoglobinopathies
  • Participation in a clinical research trial <30 days
  • Use of acute medication w/in 72 hours of intervention
  • Unstable medications <90 days
  • Abnormal liver function
  • Serum creatinine > 1.5 x upper limit of normal (ULN)
  • Anemia of any etiology
  • Blood donation w/in the last 2 months
  • Allergy or sensitivity to test articles, foods or beverages provided during the study
  • Cognitive impairment and/or unable to give informed consent

Treatment and study plan

Calcium ascorbate

Dietary Supplement

Other names: vitamin C

ascorbic acid

Dietary Supplement

Other names: vitamin C

Placebo

Other

Primary outcomes

  1. Plasma and leukocyte vitamin C concentration

    Time frame: 0, 2, 4, 8 and 24 hours

Sponsors and collaborators

Lead sponsor

NBTY, Inc.

Industry

Collaborators

  • KGK Science Inc.
  • Moyad, Mark MD MPH

Registry information

Official study title

A Randomized, Double-blind, Placebo-controlled Crossover Study Comparing the Bioavailability of Two Forms of Vitamin C in Plasma and Leukocytes Over 24 Hours.

Important dates

Study start
2011
Primary completion
2011
First posted
May 14, 2013
Registry last updated
May 14, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.